A Seoul Court ruled that the Ministry of Health, Welfare and Family Affairs should withdraw the decision to lower the price of Glivec, Switzerland based Novartis’s leukemia drug by 14 percent in September 2009.
In December, the Seoul High Court upheld the appellate court’s verdict,” stating, “Given evidence and testimony, it’s obvious that the ministry decision is improper.”
Critics say t...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.